A life-time perspective on the effects of an early invasive compared with a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome - the FRISC II 15 years follow-up

27 August 2016 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)

5 More presentations in this session

Presentation thumbnail

5-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents in unselected patients

Mr E. Christiansen (Aarhus, DK)

Presentation thumbnail

10-year follow-up of clinical outcomes in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.

Professor R. De Winter (Amsterdam, NL)

Presentation thumbnail

Comparative Efficacy of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Diabetic Patients with Multivessel Coronary Artery Disease With or Without Renal Dysfunction

Doctor U. Baber (New York, US)

Presentation thumbnail

The effect of CABG by age in patients with heart failure: 10 year follow data from the STICHES study

Professor E. Velazquez (New Haven, US)

Presentation thumbnail

ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions

Professor T. Kimura (Hirakata, JP)

Access the full session

Session thumbnail

Clinical Trial Update Coronary artery disease

The Event

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources